UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003542
Receipt number R000004240
Scientific Title A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies
Date of disclosure of the study information 2010/05/01
Last modified on 2013/04/26 16:37:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies

Acronym

KCOG-G1001s

Scientific Title

A retrospective study for the treatments and prognosis of brain metastases of gynecologic malignancies

Scientific Title:Acronym

KCOG-G1001s

Region

Japan


Condition

Condition

Brain metastases of gynecologic malignancies diagnosed with imaging modalities

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the clinical features, treatment modalities, and prognosis of patients with brain metastases of primary gynecoligic malignancies

Basic objectives2

Others

Basic objectives -Others

Retrospective study

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Age at diagnosis
Duration from the initial diagnosis to the recurrence
Duration from the initial diagnosis to the detection of brain metastases
Sites of brain metastases
Site and stage of primary disease
Pathological diagnosis of primary disease
Complication
Initial treatment for the primary disease
Effects of primary chemotherapy
Presence of pulmonary metastases
Sites of recurrence
Symptoms at recurrence
Neurological findings at diagnosis of brain metastases
Karnofsky Performance Status (KPS) and Recursive Partitioning Analysis (RPA)
Imaging modalities for the diagnosis of brain metastases
Numbers, Sites and size of brain metastases
Treatment modalities for brain metastases and their therapeutic effects and adverse effects
Status of neurologic symptoms after treatments
Prognosis
Cause of death

Key secondary outcomes

None


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients diagnosed as brain metastases of gynecologic malignancies from January, 1995 to December, 2009
Patients with pathologically confirmed gynecologic malignancies

Key exclusion criteria

Petients with history of non-gynecologic malignancies
Ptients with active non-gynecologic malignancy
Choriocarcinoma
Petients with history of treatment for central nervous system disease

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaei Nasu

Organization

Oita University, Faculty of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita 879-5593, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Oita University, Faculty of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address


TEL


Homepage URL

http://www.kcog.jp/

Email



Sponsor or person

Institute

Kansai Clinical Oncology Group

Institute

Department

Personal name



Funding Source

Organization

Kansai Clinical Oncology Group

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.sciencedirect.com/science/article/pii/S0090825812008670

Number of participants that the trial has enrolled


Results

Mean survival time of the patients with brain metastases was 12.5 months for the ovarian cancer group, 6.2 months for the corpus cancer group, and 5.0 months for the cervical cancer group; two-year overall survival rates were 19.7%, 6.1%, and 4.8%, respectively. Multivariate analysis revealed ovarian/tubal/peritoneal origin, KPS >70, single brain metastasis, absence of extracranial disease, cranial surgery, cranial radiotherapy, and chemotherapy to be independent favorable prognostic factors associated with overall survival.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 04 Month 23 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry

2011 Year 06 Month 01 Day

Date trial data considered complete


Date analysis concluded

2012 Year 04 Month 03 Day


Other

Other related information

Retrospective analysis of 139 patients with brain metastases from gynecologic malignancies was carried out as a multi-institutional study.


Management information

Registered date

2010 Year 04 Month 26 Day

Last modified on

2013 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004240


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name